From The

Expert perspectives focused on the latest bioanalytical topic & trends

Genetic Screening and Big Data’s Influence on Drug Production and Biomarker Identification

The Human Genome Project (HGP) was largely successful in its goal to identify the genetic blueprint of life. The scientific community has begun to translate this genetic information to identify new potential therapeutic targets. Further progress may be possible by continuing to screen patients and identifying subsets from a larger disease population that have increased frequency or severity of the disease. These patients may be carrying a mutation (or mutations)

Read More »

Speak To A Scientist

    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.